Marie-anne W. Meier

Basel, BS, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

A mixed-methods study investigating the potential and challenges of generic substitution of controlled substances in community pharmacies.

A mixed-methods study investigating the potential and challenges of generic substitution of controlled substances in community pharmacies.

Journal: Exploratory research in clinical and social pharmacy
Published: February 04, 2025

Adenosine Receptor 3 in Liver Cancer: Expression Variability, Epigenetic Modulation, and Enhanced Histone Deacetylase Inhibitor Effects.

Adenosine Receptor 3 in Liver Cancer: Expression Variability, Epigenetic Modulation, and Enhanced Histone Deacetylase Inhibitor Effects.

Journal: Gastro hep advances
Published: July 03, 2024

Circulating monocytes upregulate CD52 and sustain innate immune function in cirrhosis unless acute decompensation emerges.

Circulating monocytes upregulate CD52 and sustain innate immune function in cirrhosis unless acute decompensation emerges.

Journal: Journal of hepatology
Published: April 02, 2024

Real-life experience of chronic hepatitis C treatment in Switzerland: a retrospective analysis.

Real-life experience of chronic hepatitis C treatment in Switzerland: a retrospective analysis.

Journal: Swiss medical weekly
Published: December 19, 2023

AXL Expression on Homeostatic Resident Liver Macrophages Is Reduced in Cirrhosis Following GAS6 Production by Hepatic Stellate Cells.

AXL Expression on Homeostatic Resident Liver Macrophages Is Reduced in Cirrhosis Following GAS6 Production by Hepatic Stellate Cells.

Journal: Cellular and molecular gastroenterology and hepatology
Published: August 25, 2022

Circulating Cell-Free DNA Captures the Intratumor Heterogeneity in Multinodular Hepatocellular Carcinoma.

Circulating Cell-Free DNA Captures the Intratumor Heterogeneity in Multinodular Hepatocellular Carcinoma.

Journal: JCO precision oncology
Published: March 09, 2022

Patient-derived tumor organoids for personalized medicine in a patient with rare hepatocellular carcinoma with neuroendocrine differentiation: a case report.

Patient-derived tumor organoids for personalized medicine in a patient with rare hepatocellular carcinoma with neuroendocrine differentiation: a case report.

Journal: Communications medicine
Published: September 21, 2021

Epigenetic priming in chronic liver disease impacts the transcriptional and genetic landscapes of hepatocellular carcinoma.

Epigenetic priming in chronic liver disease impacts the transcriptional and genetic landscapes of hepatocellular carcinoma.

Journal: Molecular oncology
Published: July 20, 2021

Genomic analysis of focal nodular hyperplasia with associated hepatocellular carcinoma unveils its malignant potential: a case report.

Genomic analysis of focal nodular hyperplasia with associated hepatocellular carcinoma unveils its malignant potential: a case report.

Journal: Communications medicine
Published: May 17, 2021

Integrative proteogenomic characterization of hepatocellular carcinoma across etiologies and stages.

Integrative proteogenomic characterization of hepatocellular carcinoma across etiologies and stages.

Journal: Nature communications
Published: May 10, 2021

Stimulatory MAIT cell antigens reach the circulation and are efficiently metabolised and presented by human liver cells.

Stimulatory MAIT cell antigens reach the circulation and are efficiently metabolised and presented by human liver cells.

Journal: Gut
Published: February 24, 2021

Ubiquitous expression of HBsAg from integrated HBV DNA in patients with low viral load.

Ubiquitous expression of HBsAg from integrated HBV DNA in patients with low viral load.

Journal: Journal of hepatology
Published: February 11, 2021
Showing 1-12 of 16

Last Updated: 09/26/2026